• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对YC8肿瘤的二次细胞毒性T淋巴细胞反应的调节

Conditioning of the secondary cytotoxic T-lymphocyte response to YC8 tumor.

作者信息

Ghanta V K, Hiramoto N S, Soong S J, Hiramoto R N

机构信息

Department of Microbiology, University of Alabama at Birmingham, 35294-0007.

出版信息

Pharmacol Biochem Behav. 1995 Mar;50(3):399-403. doi: 10.1016/0091-3057(94)00286-r.

DOI:10.1016/0091-3057(94)00286-r
PMID:7617678
Abstract

Studies from our laboratory demonstrated that conditioned resistance to the syngeneic YC8 lymphoma was established by multiple conditioned stimulus (CS)/unconditioned stimulus (US) associations. The conditioned stimulus used was exposure to the odor of camphor for 1 h and the unconditioned stimulus was an injection of DBA/2 spleen cell alloantigen that shares minor histocompatibility determinants with the YC8 lymphoma. To demonstrate a cellular basis for immune resistance to the YC8 tumor, BALB/c mice primed with DBA/2 spleen cell alloantigen were conditioned using a single trial CS/US association paradigm. Conditioned animals showed a measurable conditioned elevation of the cytotoxic T-lymphocyte (CTL) response to the YC8 tumor. Control groups in which the CS and US were not given in the proper sequence were unable to mount a conditioned response. These studies show that a secondary CTL response can be upregulated by the central nervous system (CNS).

摘要

我们实验室的研究表明,通过多次条件刺激(CS)/非条件刺激(US)联合,可建立对同基因YC8淋巴瘤的条件性抗性。所用的条件刺激是暴露于樟脑气味1小时,非条件刺激是注射与YC8淋巴瘤共享次要组织相容性决定簇的DBA/2脾细胞同种异体抗原。为了证明对YC8肿瘤免疫抗性的细胞基础,用DBA/2脾细胞同种异体抗原致敏的BALB/c小鼠采用单次试验CS/US联合范式进行条件训练。经条件训练的动物对YC8肿瘤的细胞毒性T淋巴细胞(CTL)反应出现可测量的条件性增强。对照组中CS和US未按正确顺序给予,无法产生条件性反应。这些研究表明,中枢神经系统(CNS)可上调继发性CTL反应。

相似文献

1
Conditioning of the secondary cytotoxic T-lymphocyte response to YC8 tumor.对YC8肿瘤的二次细胞毒性T淋巴细胞反应的调节
Pharmacol Biochem Behav. 1995 Mar;50(3):399-403. doi: 10.1016/0091-3057(94)00286-r.
2
Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.同种异体抗原诱导的针对同基因肿瘤细胞的细胞毒性:克隆水平分析。
J Immunol. 1984 Jun;132(6):3218-25.
3
Eradication of a disseminated mouse lymphoma by 1,3-bis(2-chloroethyl)-1-nitrosourea is immunologically mediated and accompanied by de novo generation of anti-tumor cytotoxicity.1,3-双(2-氯乙基)-1-亚硝基脲对播散性小鼠淋巴瘤的根除是由免疫介导的,并伴有抗肿瘤细胞毒性的重新产生。
Int J Cancer. 1990 Dec 15;46(6):1088-94. doi: 10.1002/ijc.2910460623.
4
DBA/2-like minor histocompatibility antigens on a BALB/c lymphoma. A BALB/c anti-DBA/2 serum which lyses the tumor and blocks BALB/c anti-tumor and anti-DBA/2 effectors.BALB/c淋巴瘤上的DBA/2样次要组织相容性抗原。一种能裂解肿瘤并阻断BALB/c抗肿瘤和抗DBA/2效应细胞的BALB/c抗DBA/2血清。
Int J Cancer. 1985 Nov 15;36(5):617-22. doi: 10.1002/ijc.2910360516.
5
Analysis of the cellular immune response to and adoptive immunotherapy of a BALB/c lymphoma that cross-reacts with normal DBA/2 cells.对一种与正常DBA/2细胞发生交叉反应的BALB/c淋巴瘤的细胞免疫反应及过继性免疫治疗的分析。
Cancer Immunol Immunother. 1986;21(3):199-204. doi: 10.1007/BF00199362.
6
Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.同种异体反应性与肿瘤抗原:通过用正常细胞对小鼠进行同种异体免疫来产生同基因抗淋巴瘤杀伤淋巴细胞。
J Natl Cancer Inst. 1983 Feb;70(2):291-7.
7
Adoptive immunotherapy of a BALB/c lymphoma by syngeneic anti-DBA/2 immune lymphoid cells: characterization of the effector population and evidence for the role of the host's non-T cells.通过同基因抗DBA/2免疫淋巴细胞对BALB/c淋巴瘤进行过继性免疫治疗:效应细胞群体的特征及宿主非T细胞作用的证据
Cancer Immunol Immunother. 1985;20(3):198-204. doi: 10.1007/BF00205576.
8
Conditioning: a new approach to immunotherapy.预处理:免疫疗法的一种新方法。
Cancer Res. 1990 Jul 15;50(14):4295-9.
9
Passive adoptive immunotherapy of low-immunogenic BALB/c lymphoma by syngeneic alloimmune T lymphocytes.同基因同种异体免疫T淋巴细胞对低免疫原性BALB/c淋巴瘤的被动过继免疫治疗
Int J Cancer. 1984 Dec 15;34(6):807-13. doi: 10.1002/ijc.2910340611.
10
Conditioning of the allogeneic cytotoxic lymphocyte response.同种异体细胞毒性淋巴细胞反应的预处理
Pharmacol Biochem Behav. 1993 Feb;44(2):275-80. doi: 10.1016/0091-3057(93)90462-3.

引用本文的文献

1
Behavioral factors to modulate immunotherapy efficacy in cancer.调节癌症免疫疗法疗效的行为因素。
Front Immunol. 2022 Dec 16;13:1066359. doi: 10.3389/fimmu.2022.1066359. eCollection 2022.